Cortina Asset Management’s Trinity Biotech TRIB Stock Holding History

Cortina Asset Management’s Portfolio TRIB Stock Details TRIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-123,711	Closed	-$11.2M	–	251
2015 Q2	$11.2M	Sell	123,711 -3,083	-2%	-$267K	0.49%	79
2015 Q1	$12.2M	Sell	126,794 -4,143	-3%	-$383K	0.53%	70
2014 Q4	$11.5M	Buy	130,937 +21,061	+19%	+$1.81M	0.51%	81
2014 Q3	$10M	Buy	109,876 +2,109	+2%	+$228K	0.43%	93
2014 Q2	$12.4M	Buy	107,767 +21,347	+25%	+$2.53M	0.47%	86
2014 Q1	$10.5M	Buy	+86,420	New	+$11.3M	0.38%	113

Other funds holding TRIB

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return

AAM

ACK Asset Management Greenwich, Connecticut $801M AUM 60.42% 1-Year Est. Return

CCMLC

Cardinal Capital Management LLC (Connecticut) Greenwich, Connecticut $365M AUM 18.32% 1-Year Est. Return

KCM

Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return

Cortina Asset Management's TRIB Position: Q3 2015 in Review

Cortina Asset Management sold out of Trinity Biotech (TRIB) in Q3 2015, closing a stake of 123,711 shares — an estimated $11.2M sold.

Cortina Asset Management first reported a position in TRIB in Q1 2014 and held it in 6 quarters. The position peaked at $12.4M in Q2 2014. 92 funds tracked by Wall St. Rank hold TRIB as of Q3 2015.

Cortina Asset Management reported no remaining Trinity Biotech position as of Q3 2015 after selling out during the quarter.
Cortina Asset Management sold 123,711 Trinity Biotech shares in Q3 2015, an estimated $11.2M.
Cortina Asset Management first reported a position in Trinity Biotech in Q1 2014 and held it in 6 quarters.
Cortina Asset Management's Trinity Biotech position peaked at $12.4M in Q2 2014.
92 funds tracked by Wall St. Rank held Trinity Biotech as of Q3 2015.

Based on Cortina Asset Management's 13F filing for Q3 2015, filed 16 Nov 2015.